CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 62.84 CNY -2.56% Market Closed
Market Cap: 10.2B CNY

Net Margin
CanSino Biologics Inc

-14.6%
Current
-153%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-14.6%
=
Net Income
-142m
/
Revenue
971.8m

Net Margin Across Competitors

No Stocks Found

CanSino Biologics Inc
Glance View

Market Cap
10.2B CNY
Industry
Pharmaceuticals

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

CanSino Biologics Inc Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-14.6%
=
Net Income
-142m
/
Revenue
971.8m
What is the Net Margin of CanSino Biologics Inc?

Based on CanSino Biologics Inc's most recent financial statements, the company has Net Margin of -14.6%.

Back to Top